- Home
- BEAT vs GEG Comparison
BEAT vs GEG Comparison
Compare BEAT & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- GEG
- Stock Information
- Founded
- BEAT 2015
- GEG 1994
- Country
- BEAT United States
- GEG United States
- Employees
- BEAT N/A
- GEG N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- GEG Computer Software: Prepackaged Software
- Sector
- BEAT Technology
- GEG Technology
- Exchange
- BEAT Nasdaq
- GEG Nasdaq
- Market Cap
- BEAT 51.1M
- GEG 60.4M
- IPO Year
- BEAT 2021
- GEG N/A
- Fundamental
- Price
- BEAT $1.35
- GEG $2.06
- Analyst Decision
- BEAT Buy
- GEG
- Analyst Count
- BEAT 1
- GEG 0
- Target Price
- BEAT $8.00
- GEG N/A
- AVG Volume (30 Days)
- BEAT 175.9K
- GEG 11.3K
- Earning Date
- BEAT 08-13-2025
- GEG 05-07-2025
- Dividend Yield
- BEAT N/A
- GEG N/A
- EPS Growth
- BEAT N/A
- GEG N/A
- EPS
- BEAT N/A
- GEG N/A
- Revenue
- BEAT N/A
- GEG $19,626,000.00
- Revenue This Year
- BEAT N/A
- GEG N/A
- Revenue Next Year
- BEAT N/A
- GEG N/A
- P/E Ratio
- BEAT N/A
- GEG N/A
- Revenue Growth
- BEAT N/A
- GEG 64.34
- 52 Week Low
- BEAT $1.21
- GEG $1.70
- 52 Week High
- BEAT $3.48
- GEG $2.33
- Technical
- Relative Strength Index (RSI)
- BEAT 37.47
- GEG 37.99
- Support Level
- BEAT $1.49
- GEG $2.01
- Resistance Level
- BEAT $1.62
- GEG $2.18
- Average True Range (ATR)
- BEAT 0.11
- GEG 0.10
- MACD
- BEAT -0.02
- GEG -0.03
- Stochastic Oscillator
- BEAT 7.44
- GEG 16.22
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.